These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21840293)

  • 1. Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.
    Kawaguchi M; Takeda N; Hoshiko S; Yorita K; Baba T; Sawaguchi A; Nezu Y; Yoshikawa T; Fukushima T; Kataoka H
    Am J Pathol; 2011 Oct; 179(4):1815-26. PubMed ID: 21840293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis.
    Hoshiko S; Kawaguchi M; Fukushima T; Haruyama Y; Yorita K; Tanaka H; Seiki M; Inatsu H; Kitamura K; Kataoka H
    Cancer Res; 2013 Apr; 73(8):2659-70. PubMed ID: 23447577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.
    Nagaike K; Kawaguchi M; Takeda N; Fukushima T; Sawaguchi A; Kohama K; Setoyama M; Kataoka H
    Am J Pathol; 2008 Nov; 173(5):1464-75. PubMed ID: 18832587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
    Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
    Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
    Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
    Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nuclear factor-κB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin/+ model.
    Kawaguchi M; Yamamoto K; Kanemaru A; Tanaka H; Umezawa K; Fukushima T; Kataoka H
    Oncotarget; 2016 Oct; 7(42):68614-68622. PubMed ID: 27612426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.
    Szabo R; Kosa P; List K; Bugge TH
    Am J Pathol; 2009 Jun; 174(6):2015-22. PubMed ID: 19389929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptor-2 accelerates intestinal tumor formation through activation of nuclear factor-κB signaling and tumor angiogenesis in Apc
    Kawaguchi M; Yamamoto K; Kataoka H; Izumi A; Yamashita F; Kiwaki T; Nishida T; Camerer E; Fukushima T
    Cancer Sci; 2020 Apr; 111(4):1193-1202. PubMed ID: 31997435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
    Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
    J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted intestinal deletion of Rho guanine nucleotide exchange factor 7, βPIX, impairs enterocyte proliferation, villus maturation, and mucosal defenses in mice.
    Cheng K; Larabee SM; Tolaymat M; Hanscom M; Shang AC; Schledwitz A; Hu S; Drachenberg CB; Zhan M; Chahdi A; Raufman JP
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G627-G643. PubMed ID: 33566751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.
    Kawaguchi M; Kanemaru A; Sawaguchi A; Yamamoto K; Baba T; Lin CY; Johnson MD; Fukushima T; Kataoka H
    Am J Pathol; 2015 Jun; 185(6):1610-23. PubMed ID: 25842366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary.
    Godiksen S; Selzer-Plon J; Pedersen ED; Abell K; Rasmussen HB; Szabo R; Bugge TH; Vogel LK
    Biochem J; 2008 Jul; 413(2):251-9. PubMed ID: 18402552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.
    Szabo R; Molinolo A; List K; Bugge TH
    Oncogene; 2007 Mar; 26(11):1546-56. PubMed ID: 16983341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
    Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
    Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted HAI-2 deletion causes excessive proteolysis with prolonged active prostasin and depletion of HAI-1 monomer in intestinal but not epidermal epithelial cells.
    Barndt RB; Lee MJ; Huang N; Lu DD; Lee SC; Du PW; Chang CC; Tsai PB; Huang YK; Chang HM; Wang JK; Lai CH; Johnson MD; Lin CY
    Hum Mol Genet; 2021 Sep; 30(19):1833-1850. PubMed ID: 34089062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal regulation of suppression of tumorigenicity 14 (ST14) and serine peptidase inhibitor, Kunitz type -1 (SPINT1) by transcription factor CDX2.
    Danielsen ET; Olsen AK; Coskun M; Nonboe AW; Larsen S; Dahlgaard K; Bennett EP; Mitchelmore C; Vogel LK; Troelsen JT
    Sci Rep; 2018 Aug; 8(1):11813. PubMed ID: 30087389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa.
    Itoh H; Kataoka H; Tomita M; Hamasuna R; Nawa Y; Kitamura N; Koono M
    Am J Physiol Gastrointest Liver Physiol; 2000 Apr; 278(4):G635-43. PubMed ID: 10762618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
    Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
    PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.
    Oberst M; Anders J; Xie B; Singh B; Ossandon M; Johnson M; Dickson RB; Lin CY
    Am J Pathol; 2001 Apr; 158(4):1301-11. PubMed ID: 11290548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.